Edition:
United States

Danaher Corp (DHR.N)

DHR.N on New York Stock Exchange

101.34USD
20 Apr 2018
Change (% chg)

$-0.16 (-0.16%)
Prev Close
$101.50
Open
$101.62
Day's High
$102.22
Day's Low
$100.36
Volume
1,552,550
Avg. Vol
680,717
52-wk High
$104.82
52-wk Low
$78.98

Chart for

About

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins,... (more)

Overall

Beta: 1.05
Market Cap(Mil.): $70,780.17
Shares Outstanding(Mil.): 698.44
Dividend: 0.16
Yield (%): 0.63

Financials

  DHR.N Industry Sector
P/E (TTM): 28.06 33.33 33.60
EPS (TTM): 3.61 -- --
ROI: 6.23 9.89 13.19
ROE: 10.01 14.70 15.00

BRIEF-Danaher Reports Q1 Adjusted Non-Gaap Earnings Per Share $0.99

* SEES Q2 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.07 TO $1.10

Apr 19 2018

BRIEF-Danaher Corp Says CEO Thomas Joyce's FY 2017 Total Compensation Was $14.8 Mln

* DANAHER CORP SAYS PRESIDENT AND CEO THOMAS JOYCE, JR'S FY 2017 TOTAL COMPENSATION WAS $14.8 MILLION VERSUS ABOUT $13 MILLION IN FY 2016 - SEC FILING

Mar 28 2018

BRIEF-Danaher Says Entered Into $1 Bln 364-Day Revolving Credit Facility​

* DANAHER CORP SAYS ‍ON MARCH 23, 2018, CO ENTERED INTO A $1.0 BILLION 364-DAY REVOLVING CREDIT FACILITY - SEC FILING​

Mar 26 2018

BRIEF-Danaher To Acquire Integrated DNA Technologies

* DANAHER TO ACQUIRE INTEGRATED DNA TECHNOLOGIES Source text for Eikon: Further company coverage:

Mar 09 2018

BRIEF-Danaher Reports Q4 EPS Of $1.21

* SEES Q1 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.90 TO $0.93

Jan 30 2018

BRIEF-Danaher Sees FY 2018 Adjusted Earnings Per Share $4.25 To $4.35

* SEES FY 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $4.25 TO $4.35

Dec 14 2017

BRIEF-Danaher Announces Leadership Appointment

* DANAHER CORP - ‍BOARD OF DIRECTORS IS APPOINTING JOAKIM WEIDEMANIS TO POSITION OF EXECUTIVE VICE PRESIDENT OF DANAHER CORPORATION​

Nov 28 2017

BRIEF-Quidel Says Confident In Validity Of Supply Agreement With Beckman Coulter To Sell BNP Assay Assets

* QUIDEL CONFIDENT IN LEGAL STRENGTH AND VALIDITY OF SUPPLY AGREEMENT WITH BECKMAN COULTER TO SELL BNP ASSAY ASSETS

Nov 27 2017

BRIEF- IDBS says has been acquired by Danaher Corp

* U.K's IDBS says has been acquired by the life sciences platform of Danaher Corp Source text - http://bit.ly/2yYOOLb Further company coverage:

Oct 30 2017

Earnings vs. Estimates